Stifel Reiterates Hold on Avanos Medical, Maintains $25 Price Target
Portfolio Pulse from richadhand@benzinga.com
Stifel analyst Rick Wise has reiterated a Hold rating on Avanos Medical (NYSE:AVNS) and maintained a $25 price target.
June 21, 2023 | 1:38 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Stifel analyst reiterates Hold rating on Avanos Medical (AVNS) and maintains $25 price target.
The news is directly related to Avanos Medical (AVNS) as Stifel analyst Rick Wise reiterated a Hold rating and maintained a $25 price target. This indicates that the analyst's view on the stock remains unchanged, which is likely to have a neutral impact on the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 60
RELEVANCE 100